AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule
Fierce Pharma
FEBRUARY 12, 2024
And the good news from an industry perspective is that deal took less than three months to complete. AbbVie has closed its $10.1 billion buyout of antibody-drug conjugate specialist ImmunoGen. AbbVie has closed its $10.1 billion buyout of antibody-drug conjugate specialist ImmunoGen.
Let's personalize your content